Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NHI Insider Trading

NATIONAL HEALTH INVESTORS INC | Real Estate Investment Trusts

Comprehensive Trading Performance Summary

The investment history of corporate insiders at NATIONAL HEALTH INVESTORS INC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Real Estate Investment Trusts sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2024-05-31 23:20 2024-05-31 MCCABE ROBERT A JR Director BUY $65.83 437 $28,768 21,585 +2.1%
2024-02-29 02:20 2024-02-27 SWAFFORD CHARLOTTE A Director BUY $58.69 10,000 $586,882 110,185 +10.0%
2023-09-01 01:16 2023-08-30 Jobe James R Director BUY $51.40 1,000 $51,398 14,979 +7.2%
2022-12-16 03:48 2022-12-14 ADAMS ROBERT G Director BUY $56.60 1,000 $56,600 180,548 +0.6%
2022-08-16 18:27 2022-08-15 ADAMS ROBERT G Director BUY $65.93 1,500 $98,895 85,411 +1.8%
2022-01-05 00:49 2021-12-30 ADAMS ROBERT G Director BUY $57.25 2,000 $114,500 170,000 +1.2%
2021-12-02 00:59 2021-11-29 WEBB ROBERT T Director BUY $52.02 3,000 $156,060 42,000 +7.7%
2021-10-01 23:41 2021-09-30 WEBB ROBERT T Director BUY $53.86 2,000 $107,715 39,000 +5.4%
2021-10-01 23:39 2021-09-29 Mendelsohn D. Eric Officer - CEO and President BUY $54.38 2,000 $108,757 46,256 +4.5%
2021-09-21 00:25 2021-09-16 WEBB ROBERT T Director BUY $57.38 3,000 $172,125 37,000 +8.8%
2021-09-17 00:19 2021-09-14 WEBB ROBERT T Director BUY $58.00 1,500 $87,000 34,000 +4.6%
2021-09-10 23:54 2021-09-10 WEBB ROBERT T Director BUY $58.50 1,500 $87,750 32,500 +4.8%
2021-09-10 23:51 2021-09-09 MCCABE ROBERT A JR Director BUY $59.84 468 $28,003 17,456 +2.8%
2021-06-21 23:58 2021-06-17 WEBB ROBERT T Director BUY $65.00 1,184 $76,960 31,000 +4.0%
2020-12-15 01:11 2020-12-14 ADAMS ROBERT G Director BUY $67.75 2,000 $135,500 168,000 +1.2%
2020-11-19 19:53 2020-11-17 ADAMS ROBERT G Director BUY $66.35 5,000 $331,770 83,911 +6.3%
2020-05-16 00:19 2020-05-13 ADAMS ROBERT G Director BUY $48.36 425 $20,553 339,579 +0.1%
2020-03-26 00:57 2020-03-23 ADAMS W ANDREW Director BUY $36.16 27,000 $976,320 759,784 +3.7%
2020-03-18 01:24 2020-03-16 WEBB ROBERT T Director BUY $43.17 4,622 $199,548 29,816 +18.3%
2020-03-13 23:04 2020-03-12 Mendelsohn D. Eric Officer - CEO and President BUY $60.27 2,000 $120,549 46,256 +4.5%
2020-02-26 03:17 2020-02-24 PASCOE KEVIN CARLTON Officer - Chief Investment Officer SELL $90.56 3,043 $275,583 30,625 -9.0%
2020-02-26 03:11 2020-02-24 Mendelsohn D. Eric Officer - CEO and President SELL $90.58 4,000 $362,330 44,256 -8.3%
2019-09-26 00:50 2019-09-24 Jobe James R Director SELL $83.23 900 $74,911 12,052 -6.9%
2019-08-15 18:28 2019-08-13 PASCOE KEVIN CARLTON Officer - Chief Investment Officer SELL $82.15 2,000 $164,293 26,726 -7.0%
2019-02-26 03:07 2019-02-21 MCCABE ROBERT A JR Director SELL $78.04 1,181 $92,168 13,932 -7.8%
2018-12-19 01:55 2018-12-14 PASCOE KEVIN CARLTON Officer - Chief Investment Officer SELL $79.60 2,070 $164,772 25,123 -7.6%
2018-12-15 00:39 2018-12-12 Gaines Kristin Sallee Officer - Chief Credit Officer SELL $80.36 10,708 $860,526 38,411 -21.8%
2018-11-28 02:01 2018-11-26 MCCABE ROBERT A JR Director SELL $75.41 1,250 $94,263 13,120 -8.7%
2018-05-30 00:28 2018-05-25 MCCABE ROBERT A JR Director BUY $72.00 285 $20,520 11,288 +2.6%
2018-02-28 01:09 2018-02-26 MCCABE ROBERT A JR Director BUY $65.69 312 $20,495 11,003 +2.9%
2018-02-24 00:37 2018-02-22 Mendelsohn D. Eric Officer - CEO and President BUY $65.47 2,000 $130,948 12,080 +19.8%
2018-02-24 00:35 2018-02-22 Spaid John L Officer - Exec. VP of Finance BUY $64.95 500 $32,475 971 +106.2%
2017-12-01 02:37 2017-11-29 MCCABE ROBERT A JR Director BUY $78.23 263 $20,574 10,691 +2.5%
2017-08-28 23:57 2017-08-28 MCCABE ROBERT A JR Director BUY $79.94 259 $20,704 10,428 +2.5%
2017-08-28 23:53 2017-08-24 PASCOE KEVIN CARLTON Officer - Chief Investment Officer SELL $79.80 2,000 $159,600 21,228 -8.6%
2016-09-01 00:31 2016-08-30 MCCABE ROBERT A JR Director SELL $80.29 800 $64,233 10,021 -7.4%
2016-06-30 04:33 2016-06-28 Gaines Kristin Sallee Officer - Chief Credit Officer OPT+S $73.98 8,652 $640,072 33,069 0.0%
2016-06-14 23:46 2016-06-13 MCCABE ROBERT A JR Director SELL $71.61 1,250 $89,516 9,736 -11.4%
2016-05-12 20:21 2016-05-10 PASCOE KEVIN CARLTON Officer - EVP - Investments SELL $70.72 2,000 $141,437 19,241 -9.4%
2016-03-29 23:19 2016-03-28 Hopkins Roger R Officer - Chief Accounting Officer SELL $65.45 10,000 $654,500 24,558 -28.9%
2015-12-12 01:15 2015-12-11 MCCABE ROBERT A JR Director BUY $59.10 35 $2,069 8,130 +0.4%
2015-12-02 00:06 2015-11-27 MCCABE ROBERT A JR Director BUY $60.34 130 $7,844 8,095 +1.6%
2015-11-18 00:59 2015-11-17 Mendelsohn D. Eric Officer - CEO and President BUY $56.12 1,000 $56,120 6,000 +20.0%
2015-08-31 23:13 2015-08-31 MCCABE ROBERT A JR Director BUY $56.21 310 $17,425 7,965 +4.0%
2015-08-27 23:45 2015-08-26 ADAMS W ANDREW Director BUY $55.50 2,000 $111,000 11,707 +20.6%
2015-08-26 23:15 2015-08-26 Mendelsohn D. Eric Officer - Interim CEO and President BUY $55.38 750 $41,538 5,000 +17.6%
2015-08-26 23:12 2015-08-25 WEBB ROBERT T Director BUY $56.75 5,000 $283,750 25,194 +24.8%
2015-08-25 23:32 2015-08-24 Mendelsohn D. Eric Officer - Interim CEO and President BUY $56.99 750 $42,743 4,250 +21.4%
2015-08-25 23:30 2015-08-25 Jobe James R Director BUY $56.68 100 $5,668 4,425 +2.3%
2015-08-14 00:17 2015-08-13 Mendelsohn D. Eric Officer - Interim CEO and President BUY $58.80 1,500 $88,200 3,500 +75.0%
SHOW ENTRIES
1-50 OF 119

How to Interpret $NHI Trades

Not every insider transaction in NATIONAL HEALTH INVESTORS INC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NHI shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NHI

Insider activity data for NATIONAL HEALTH INVESTORS INC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NHI, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.